BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32621177)

  • 1. Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemia.
    Kunadt D; Dransfeld C; Dill C; Schmiedgen M; Kramer M; Altmann H; Röllig C; Bornhäuser M; Mahlknecht U; Schaich M; Stölzel F
    Ann Hematol; 2020 Sep; 99(9):2173-2180. PubMed ID: 32621177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
    Cao HX; Miao CF; Yan L; Tang P; Zhang LR; Sun L
    J Transl Med; 2017 Nov; 15(1):235. PubMed ID: 29141648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein and multidrug resistance-associated protein-1 expression in acute myeloid leukemia: Biological and prognosis implications.
    da Silveira Júnior LS; Soares VL; Jardim da Silva AS; Gil EA; Pereira de Araújo MDG; Merces Gonçalves CA; Paiva AS; Moura de Oliveira TM; Oliveira GHM; Kramer Cavacanti E Silva DG; de Araújo Moura Lemos TM; Moretti Rebecchi IM; de Farias Sales VS; Luchessi AD; Cavalcanti Júnior GB
    Int J Lab Hematol; 2020 Oct; 42(5):594-603. PubMed ID: 32452631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wilms Tumor-1 (WT1) rs2234593 variant is a prognostic factor in normal karyotype acute myeloid leukemia.
    Niavarani A; Horswell S; Sadri R; Bonnet D
    Ann Hematol; 2016 Jan; 95(2):179-90. PubMed ID: 26499507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
    Do JH; Oh SH; Song EJ; Chung JS; Kang CD; Lee EY
    Korean J Lab Med; 2007 Aug; 27(4):229-36. PubMed ID: 18094581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MRP1 gene in acute leukemia.
    Mahjoubi F; Golalipour M; Ghavamzadeh A; Alimoghaddam K
    Sao Paulo Med J; 2008 May; 126(3):172-9. PubMed ID: 18711657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility of lung cancer associated with common variants in the 3' untranslated regions of the adenosine triphosphate-binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export.
    Wang H; Jin G; Wang H; Liu G; Qian J; Jin L; Wei Q; Shen H; Huang W; Lu D
    Cancer; 2009 Feb; 115(3):595-607. PubMed ID: 19107762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML).
    Zhu KW; Chen P; Zhang DY; Yan H; Liu H; Cen LN; Liu YL; Cao S; Zhou G; Zeng H; Chen SP; Zhao XL; Chen XP
    J Transl Med; 2018 Apr; 16(1):90. PubMed ID: 29631596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.
    Zidan MA; Kamal Shaaban HM; Elghannam DM
    Hematology; 2014 Jul; 19(5):267-74. PubMed ID: 24074521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype.
    Choi H; Jung C; Sohn SK; Kim S; Kim HJ; Kim YK; Kim T; Zhang Z; Shin ES; Lee JE; Moon JH; Kim SH; Kim KH; Mun YC; Kim H; Park J; Kim J; Kim D
    Br J Haematol; 2013 Oct; 163(1):62-71. PubMed ID: 24159609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
    Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
    Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunorelated gene polymorphisms associated with acute myeloid leukemia.
    Liu Q; Hua M; Yan S; Zhang C; Wang R; Yang X; Han F; Hou M; Ma D
    Clin Exp Immunol; 2020 Sep; 201(3):266-278. PubMed ID: 32349161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients.
    Paprocka M; Bielawska-Pohl A; Rossowska J; Krawczenko A; Duś D; Kiełbiński M; Haus O; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Haematol; 2017 Nov; 99(5):415-422. PubMed ID: 28805931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCM7 polymorphisms associated with the AML relapse and overall survival.
    Lee JS; Cheong HS; Koh Y; Ahn KS; Shin HD; Yoon SS
    Ann Hematol; 2017 Jan; 96(1):93-98. PubMed ID: 27837251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of SNP of P53 genes pathway on the adult AML patients.
    Abdel Hamid TM; El Gammal MM; Eibead GT; Saber MM; Abol Elazm OM
    Hematology; 2015 Jul; 20(6):328-35. PubMed ID: 25232917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of TET2 SNP rs2454206 with improved survival in children with acute myeloid leukemia featuring intermediate-risk cytogenetics.
    Wang X; Chen X; Yang Z; Dou H; Lu L; Bi J; Zou L; Yu J; Bao L
    Genes Chromosomes Cancer; 2018 Aug; 57(8):379-386. PubMed ID: 29664232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients.
    Park S; Choi H; Kim HJ; Ahn JS; Kim HJ; Kim SH; Mun YC; Jung CW; Kim DDH
    Ann Hematol; 2018 Jun; 97(6):955-965. PubMed ID: 29500710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
    Damm F; Heuser M; Morgan M; Yun H; Grosshennig A; Göhring G; Schlegelberger B; Döhner K; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Döhner H; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 Feb; 28(4):578-85. PubMed ID: 20038731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype.
    Jakobsen Falk I; Fyrberg A; Paul E; Nahi H; Hermanson M; Rosenquist R; Höglund M; Palmqvist L; Stockelberg D; Wei Y; Gréen H; Lotfi K
    Br J Haematol; 2014 Dec; 167(5):671-80. PubMed ID: 25155901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.